Correlation Between Wuhan Hvsen and Structure Therapeutics
Specify exactly 2 symbols:
By analyzing existing cross correlation between Wuhan Hvsen Biotechnology and Structure Therapeutics American, you can compare the effects of market volatilities on Wuhan Hvsen and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wuhan Hvsen with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wuhan Hvsen and Structure Therapeutics.
Diversification Opportunities for Wuhan Hvsen and Structure Therapeutics
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Wuhan and Structure is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Wuhan Hvsen Biotechnology and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Wuhan Hvsen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wuhan Hvsen Biotechnology are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Wuhan Hvsen i.e., Wuhan Hvsen and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Wuhan Hvsen and Structure Therapeutics
Assuming the 90 days trading horizon Wuhan Hvsen Biotechnology is expected to under-perform the Structure Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Wuhan Hvsen Biotechnology is 7.91 times less risky than Structure Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Structure Therapeutics American is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 2,088 in Structure Therapeutics American on September 11, 2025 and sell it today you would earn a total of 4,641 from holding Structure Therapeutics American or generate 222.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 90.63% |
| Values | Daily Returns |
Wuhan Hvsen Biotechnology vs. Structure Therapeutics America
Performance |
| Timeline |
| Wuhan Hvsen Biotechnology |
| Structure Therapeutics |
Wuhan Hvsen and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Wuhan Hvsen and Structure Therapeutics
The main advantage of trading using opposite Wuhan Hvsen and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wuhan Hvsen position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Wuhan Hvsen vs. Tongling Nonferrous Metals | Wuhan Hvsen vs. Hainan Mining Co | Wuhan Hvsen vs. RoadMain T Co | Wuhan Hvsen vs. Xinjiang Beixin RoadBridge |
| Structure Therapeutics vs. Edgewise Therapeutics | Structure Therapeutics vs. Viridian Therapeutics | Structure Therapeutics vs. Uniqure NV | Structure Therapeutics vs. Ocular Therapeutix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |